| John M Richardson, | |
|
140 Market Center Dr, Alabaster, AL 35007-8610 | |
| (205) 663-4500 | |
| Not Available |
| Full Name | John M Richardson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 140 Market Center Dr, Alabaster, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316204191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14937 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John M Richardson, 140 Market Center Dr, Alabaster, AL 35007-8610 Ph: (205) 663-4500 | John M Richardson, 140 Market Center Dr, Alabaster, AL 35007-8610 Ph: (205) 663-4500 |
News Archive
At the Institute of Medicine (IOM) and National Research Council (NRC) meeting held on March 24, Institute of Food Technologists (IFT) food scientist Dr. Frank Busta addressed food safety gaps in the Food Protection Plan by the U.S. Food and Drug Administration (FDA).
A UCSF institute aimed at accelerating the pace of translating science into real-life solutions for patients has received $112 million from the National Institutes of Health to expand its work over the next five years.
Dalhousie Medical School cancer researcher Dr. Patrick Lee has proven that a common virus can infect and kill breast cancer stem cells.
Diabetic nephropathy is one of the most serious complications related to diabetes, often leading to end-stage kidney disease. Purple corn grown in Peru and Chile is a relative of blue corn, which is readily available in the U.S.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
› Verified 1 days ago
Mr. James L Gann, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 1st St N, Alabaster, AL 35007 Phone: 205-621-2310 Fax: 205-621-2318 | |
Dr. Cristal O'loughlin-anderson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 S Colonial Dr, Alabaster, AL 35007 Phone: 205-564-2609 Fax: 205-564-2608 | |
Dr. Allison Kay Kurts, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Old Spanish Trl, Alabaster, AL 35007 Phone: 256-679-0898 | |
Chris Cawood, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 199 Corporate Woods Dr, Alabaster, AL 35007 Phone: 334-444-8189 | |
Heather R Foran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9085 Highway 119, Alabaster, AL 35007 Phone: 205-624-6224 Fax: 205-624-6227 | |
Mr. Stephen Keith Levan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1022 Fisrt Street North, Alabaster, AL 35007 Phone: 205-621-2310 | |
Mr. Jones Stephen Davis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1022 First Street North, Suite 100, Alabaster, AL 35007 Phone: 205-621-2310 Fax: 205-621-2318 |